Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Provention Bio Initiates First-in-Human Study of Coxsackievirus B Vaccine Candidate PRV-101

americanpharmaceuticalreviewJanuary 06, 2021

Tag: PRV-101 , CVB , Provention Bio , PROVENT , T1D

PharmaSources Customer Service